Research Guide
Why safety and manufacturing can change everything
A strong efficacy signal can still fail if safety, exposure, dosing, durability, or manufacturing cannot support clinical and commercial use. CMC is often where a scientific idea becomes an investable product or stalls.
What to check first
Start with the evidence that can change value: clinical relevance, regulatory path, competitive context, financing needs, and whether the company can reach the next milestone.
How Drugnews uses this guide
We apply these frameworks when writing company research, paid analysis, and client-facing content so that readers can follow the logic behind each judgment.